WAYNE, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced U.S. Food and Drug Administration (FDA) 510(k) ...
Teleflex Incorporated announced the FDA 510(k) clearance for an expansion of the QuikClot Control+™ Hemostatic Device's indications, now including all grades of internal and external bleeding.
Hosted on MSN
Teleflex Announces FDA Clearance for Expanded Use of QuikClot Control+ Hemostatic Device
WAYNE, PA — Teleflex Incorporated (NYSE: TFX) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the Indications for Use of its QuikClot Control+™ Hemostatic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback